Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The EU notified body code of conduct: a key tool to avoid stricter regulation or too complex to enforce?

This article was originally published in SRA

Executive Summary

Now that an initial version of a code of conduct for notified bodies in the EU has been agreed, will it be enough to convince the European Commission that these testing and certification organisations are on their own able to raise standards across the sector to a sufficiently high level? In other words, will the code be enough to stop the commission and EU lawmakers from introducing tighter notified body-related legislation?

Latest Headlines
See All
UsernamePublicRestriction

Register

MT039319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel